Differential expression of Lumican, Mimecan, Annexin A5 and Serotransferrin in ectopic and matched eutopic endometrium in ovarian endometriosis: a case-control study
article
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
This proteomic study found that Mimecan and Lumican proteins were upregulated in ectopic endometrium compared to matched eutopic endometrium from women with ovarian endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIM: Endometriosis is a debilitating disease marked by recurrent gynecological proliferations. The present study aimed at performing differential proteomic analysis of matched eutopic and ectopic endometrium from women with ovarian endometriosis. MATERIALS AND METHODS: Proteomes were resolved using nano LC-MS and further identified and quantified using ProteinLynx Global SERVER (PLGS) software. Selected proteins were further chosen for validation by real time-polymerase chain reaction (RT-PCR). RESULTS: The protein profiles uncovered several differentially expressed proteins in the diseased sample (ectopic endometrium) as compared to the reference sample (eutopic endometrium). The study involved an advanced proteomic approach, nano LC-MS, and validates for the first time the upregulation of Mimecan and Lumican proteins in endometriosis. CONCLUSIONS: These proteins may hence prove as potentially useful tools in the search for diagnostic markers for early detection of the disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: A heterogeneous tissue with a complex disease via openalex
- Combined mRNA microarray and proteomic analysis of eutopic endometrium of women with and without endometriosis via openalex
- Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis via openalex
- Epidemiology of endometriosis and its comorbidities via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Investigation of serum proteome alterations in human endometriosis via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Proteomics Analysis of Plasma for Early Diagnosis of Endometriosis via openalex
- “Spot”-ting differences between the ectopic and eutopic endometrium of endometriosis patients via openalex
- W1660497171 via openalex
- W2943113867 via openalex
- W1965353444 via openalex
- W2006145907 via openalex
- W2022717979 via openalex
- W2026285718 via openalex
- W2101769790 via openalex
- W2113667731 via openalex
- W2118623784 via openalex
- W2120303579 via openalex
Cited by (6)
- Overexpression of miR-21-5p as a potential pathogenesis marker for ovarian endometriosis 2025
- Translational aspects of the endometriosis epigenome 2023
- How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis 2023
- Omics-based novel strategies in the diagnosis of endometriosis 2023
- Evaluation of new biomarkers in stage III and IV endometriosis 2023
- Proteins in urine - Possible biomarkers of endometriosis 2023
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:42.008780+00:00
License: CC0
· commercial use OK